Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism

Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism JOURNAL OF NEUROSCIENCE RESEARCH LONGO, F. M., MANTHORPE, M., Xie, Y. M., VARON, S. 1997; 48 (1): 1-17

Abstract

Cyclized peptides corresponding to beta-loop regions of NGF were purified by HPLC and assayed for neurotrophic activity using DRG neurons. Peptides with the highest activity corresponded to loop region 29-35, a domain likely to interact with the p75 receptor. Unexpectedly, activity was confined to late-eluting HPLC fractions containing peptide multimers and primarily promoted neuronal survival without neurite outgrowth. Directed synthesis of dimer and monomer cyclized peptides demonstrated that dimers acted as partial NGF agonists in that they had both survival-promoting and NGF-inhibiting activity while monomer and linear peptides were inactive. Dimer activity was not affected by the Trk inhibitor K252a but was blocked by p75 receptor antibody and absent using p75 null mutant neurons. These studies suggest that region 29-35 peptide derivatives inhibit neuronal death via a structure- and p75-dependent mechanism.

View details for Web of Science ID A1997WQ34600001

View details for PubMedID 9086177